Valuation: The ACME Laboratories Ltd.

Market Cap 16.82B 135M 122M 113M 102M 192M 12.69B 199M 1.35B 537M 6.78B 505M 494M 21.51B P/E 2025
6.29x
P/E 2026 6.51x
Enterprise Value 38.74B 310M 281M 260M 234M 442M 29.22B 457M 3.12B 1.24B 15.61B 1.16B 1.14B 49.55B EV / Sales 2025
1.06x
EV / Sales 2026 0.95x
Free-Float
51.84%
Yield 2025
4.85%
Yield 2026 -
1 day-0.63%
1 week+1.66%
Current month+2.05%
1 month+3.25%
3 months-4.45%
6 months+4.47%
Current year+12.13%
1 week 77.4
Extreme 77.4
81.1
1 month 76.5
Extreme 76.5
81.1
Current year 70.6
Extreme 70.6
88.7
1 year 68.6
Extreme 68.6
88.7
3 years 62.6
Extreme 62.6
94.5
5 years 62.6
Extreme 62.6
111
10 years 54.2
Extreme 54.2
122.4
Manager TitleAgeSince
Chief Executive Officer 82 30/09/1995
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 82 17/03/1975
Director/Board Member 76 15/04/1981
Chairman 69 05/09/2018
Change 5-day change 1-year change 3-year change Capi.($)
-0.63%+1.66%+11.34%-6.47% 135M
+1.26%+6.61%+40.79%+136.32% 1,286B
+0.79%+3.45%+45.84%+93.52% 688B
+0.20%+1.28%+26.97%+113.70% 521B
-0.44%+3.69%+41.45%+68.91% 386B
+0.55%+0.70%+59.02%+44.62% 364B
-0.12%+0.74%+28.39%+58.54% 302B
+0.37%+0.37%+3.33%+37.27% 287B
-0.30%+1.14%+38.29%+72.46% 252B
+0.08%+0.71%+34.44%+124.95% 208B
Average +0.18%+2.11%+32.99%+74.38% 429B
Weighted average by Cap. +0.54%+3.26%+37.70%+96.50%

Financials

2025 2026
Net sales 35.94B 287M 261M 241M 217M 410M 27.11B 424M 2.89B 1.15B 14.48B 1.08B 1.06B 45.96B 41.6B 333M 302M 279M 252M 474M 31.37B 491M 3.35B 1.33B 16.76B 1.25B 1.22B 53.2B
Net income 2.43B 19.43M 17.6M 16.28M 14.69M 27.69M 1.83B 28.66M 196M 77.56M 978M 72.9M 71.36M 3.11B 2.68B 21.41M 19.4M 17.94M 16.19M 30.51M 2.02B 31.58M 216M 85.46M 1.08B 80.33M 78.63M 3.42B
Net Debt 22.87B 183M 166M 153M 138M 261M 17.25B 270M 1.84B 731M 9.22B 687M 672M 29.25B 21.92B 175M 159M 147M 133M 250M 16.53B 259M 1.77B 700M 8.83B 658M 644M 28.03B
Projected Income Statement - Annual - The ACME Laboratories Ltd.
Logo The ACME Laboratories Ltd.
The ACME Laboratories Limited is a Bangladesh-based company, which is engaged in manufacturing, marketing, and distribution of pharmaceuticals formulation products. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products, which include human drugs comprising dosages like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, and sachet products. It also offers veterinary drugs comprising dosages like bolus, liquid, injection, water-soluble powder, premix, and herbal drugs comprising dosages like liquid, capsule, tablet, cream, and ointment. The products of the Company are sold in domestic and international markets, respectively. Its factory is situated at Dhulivita, Dhamrai, Dhaka, and Bangladesh. It produces approximately 800 products in different dosage forms.
Employees
9,025
Date Price Change Volume
12/11/26 BDT 79.50 -0.62% 159,676
11/11/26 BDT 80.00 -0.50% 279,654
10/11/26 BDT 80.40 +1.52% 272,519
09/11/26 BDT 79.20 +2.06% 368,525
08/11/26 BDT 77.60 -0.77% 114,020
  1. Stock Market
  2. Stocks
  3. ACMELAB Stock